Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment
Clinical trial NCT05065762 · COMPLETED
Trial details
- NCT number
- NCT05065762
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-02-07
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.